Gilead Sciences (GILD) Profit After Tax (2009 - 2026)

Gilead Sciences (GILD) reported Profit After Tax of $2.0 billion for Q1 2026, up 53.69% on a YoY basis from $1.3 billion in Q1 2025, and down 7.42% quarter-over-quarter from $2.2 billion in Q4 2025.

Gilead Sciences (GILD) Profit After Tax (2009 - 2026) Analysis & Trends

Gilead Sciences has reported Profit After Tax for 18 years, with the latest figure at $2.0 billion in Q1 2026.

  • For the quarter ending Q1 2026, Profit After Tax rose 53.69% year-over-year to $2.0 billion; the trailing twelve-month figure through Mar 2026 stood at $9.2 billion (up 54.5% YoY), and the FY2025 full-year result was $8.5 billion, up 1672.92% from the prior year.
  • Profit After Tax for Q1 2026 stood at $2.0 billion, down from $2.2 billion in the prior quarter.
  • The five-year high for Profit After Tax was $3.1 billion in Q3 2025, with the low at -$4.2 billion in Q1 2024.
  • Historically, Profit After Tax has averaged $1.2 billion across 5 years, with a median of $1.6 billion in 2022.
  • Annual changes were most pronounced in 2023 — Profit After Tax jumped 5215.79% — and 2024, when it sank 512.87%.
  • Gilead Sciences' Profit After Tax stood at $1.6 billion in 2022, then slipped by 14.68% to $1.4 billion in 2023, then increased by 29.48% to $1.8 billion in 2024, then increased by 22.43% to $2.2 billion in 2025, then slipped by 7.42% to $2.0 billion in 2026.
  • The last three Profit After Tax figures came in at $2.0 billion (Q1 2026), $2.2 billion (Q4 2025), and $3.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 2.48 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 7.40 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 5.24 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 697.00 Mn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -4.24 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 1.82 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 2.02 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 2.71 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 2.68 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.02 Bn
Dec 31, 2025 2.18 Bn
Sep 30, 2025 3.05 Bn
Jun 30, 2025 1.96 Bn
Mar 31, 2025 1.32 Bn
Dec 31, 2024 1.78 Bn
Sep 30, 2024 1.25 Bn
Jun 30, 2024 1.61 Bn
Mar 31, 2024 -4.17 Bn
Dec 31, 2023 1.38 Bn
Sep 30, 2023 2.17 Bn
Jun 30, 2023 1.05 Bn
Mar 31, 2023 1.01 Bn
Dec 31, 2022 1.61 Bn
Sep 30, 2022 1.79 Bn
Jun 30, 2022 1.14 Bn
Mar 31, 2022 19.00 Mn
Dec 31, 2021 358.00 Mn
Sep 30, 2021 2.59 Bn
Jun 30, 2021 1.52 Bn